These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35950147)

  • 1. Clinical Characteristics and Treatment Outcomes of Scleromyxedema: A 10-Year Retrospective Survey.
    Ansari A; Erfani Z; Daneshpazhooh M; Mahmoudi L; Saffarian Z; Kamyab K; Mahmoudi H
    Case Rep Dermatol; 2022; 14(2):178-183. PubMed ID: 35950147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scleromyxedema with multiple systemic involvement: Successful treatment with intravenous immunoglobulin.
    Kim S; Park TH; Lee SM; Kim YH; Cho MK; Whang KU; Kim HS
    Dermatol Ther; 2020 May; 33(3):e13378. PubMed ID: 32250023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scleromyxedema with subcutaneous nodules: successful treatment with thalidomide and intravenous immunoglobulin.
    Dolenc-Voljč M; Jurčić V; Hočevar A; Tomšič M
    Case Rep Dermatol; 2013; 5(3):309-15. PubMed ID: 24348379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrete Papular Lichen Myxedematosus and Scleromyxedema with Hypothyroidism: A Report of Two Cases.
    Shenoy A; Steixner J; Beltrani V; Gottlieb A
    Case Rep Dermatol; 2019; 11(1):64-70. PubMed ID: 31011315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atypical scleromyxedema with a granulomatous histological pattern and delayed sclerosis].
    de Cambourg G; Goussot R; Wettlé C; Cribier B
    Ann Dermatol Venereol; 2016 May; 143(5):382-6. PubMed ID: 26969478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scleromyxedema in a 21 year old female patient with acute lymphoblastic leukemia: a case report.
    Rabee H; Tayem L; Gharbeyah M; Abugaber D
    BMC Dermatol; 2020 Dec; 20(1):18. PubMed ID: 33276772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scleromyxedema.
    Hoffmann JHO; Enk AH
    J Dtsch Dermatol Ges; 2020 Dec; 18(12):1449-1467. PubMed ID: 33373143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periocular Scleromyxedema.
    Qureshi F; Dharmasena A; Leatherbarrow B
    Ophthalmic Plast Reconstr Surg; 2015; 31(5):e119-20. PubMed ID: 24807804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Scleromyxedema].
    Neufeld M; Sunderkötter C; Moritz RKC
    Hautarzt; 2018 Nov; 69(11):916-921. PubMed ID: 30135969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: Scleromyxedema associated with a monoclonal gammapathy: Successful treatment with intravenous immunoglobulins.
    Wang SS; Chen QY; Xiang LH
    Front Immunol; 2022; 13():1099918. PubMed ID: 36713453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing scleromyxedema with intravenous immunoglobulin: acute worsening of scleromyxedema with biclonal gammopathy.
    Manousaridis I; Loeser C; Goerdt S; Hassel JC
    Acta Dermatovenerol Alp Pannonica Adriat; 2010 Dec; 19(4):15-9. PubMed ID: 21390475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoclonal immunoglobulin (M-Ig) and skin diseases from the group of mucinoses--scleredema adultorum Buschke and scleromyxedema. Description of four cases and an overview of therapies].
    Adam Z; Szturz P; Krejčí M; Vašků V; Pour L; Michalková E; Ševčíková S; Čermáková Z; Veselý K; Vaníček J; Pourová E; Král Z; Mayer J
    Vnitr Lek; 2015 Dec; 61(12):1072-87. PubMed ID: 26806503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination oral prednisone and intravenous immunoglobulin in the treatment of scleromyxedema.
    Majeski C; Taher M; Grewal P; Dytoc M; Lauzon G
    J Cutan Med Surg; 2005 Jun; 9(3):99-104. PubMed ID: 16392012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scleromyxedema: a case series highlighting long-term outcomes of treatment with intravenous immunoglobulin (IVIG).
    Blum M; Wigley FM; Hummers LK
    Medicine (Baltimore); 2008 Jan; 87(1):10-20. PubMed ID: 18204366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scleromyxedema without paraproteinemia.
    Abarzúa AA; Giesen LF; Sandoval MO; González SB
    Int J Dermatol; 2014 Aug; 53(8):971-4. PubMed ID: 24527753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of intravenous immunoglobulin in Arndt-Gottron scleromyxedema].
    Lopez L; Wierzbicka-Hainaut E; Villers A; Guillet G
    Ann Dermatol Venereol; 2009 Apr; 136(4):330-6. PubMed ID: 19361699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulomatous scleromyxedema: case report and literature review.
    Shlyankevich J; Stetsenko GY; George E; Lantz DM; Burwick NR; Vary JC
    Am J Dermatopathol; 2015 Mar; 37(3):240-5. PubMed ID: 24247576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous gammaglobulin and thalidomide may be an effective therapeutic combination in refractory scleromyxedema: case report and discussion of the literature.
    Efthimiou P; Blanco M
    Semin Arthritis Rheum; 2008 Dec; 38(3):188-94. PubMed ID: 18221985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Encephalitic Syndrome Induced by Scleromyxedema.
    Magira EE; Malouchou A; Karathanasi V; Mavropoulou N; Siempos II; Vourlakou C; Sykaras A; Anastasiadis G
    Am J Med Sci; 2020 Aug; 360(2):192-195. PubMed ID: 32540147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scleromyxedema Without Monoclonal Gammopathy Treated with Intravenous Immunoglobulins.
    Letzelter M; Grimaux X
    Acta Dermatovenerol Croat; 2021 Apr; 291(1):51-53. PubMed ID: 34477065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.